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ABSTRACT
Vitiligo is a depigmentation disorder with complex causes. Nonetheless, recent progress has been made to unravel the pathophysiology of vitiligo. In 
this review, we provide an overview of the currently known herbal medicine for vitiligo treatment and also highlighted the herbs that have been used 
in clinical trials. In view of traditional uses, herbs such as Ammi visnaga L., Angelica sinensis, Eclipta alba L, Ginkgo biloba, Picrorhiza kurroa Royle Ex 
Benth, and Psoralea corylifolia L, have been highlighted. Enormous efforts in vitiligo drug discovery are currently needed. Interleukin-17 inhibition, 
tumor necrosis factor-alpha inhibition, heat shock protein-70i (HSP70i) inhibition, keratinocyte turnover modulators, and regulatory T cells (Tregs) 
modulators have been discussed as promising new targets for vitiligo drug development. Thus, we strongly believe that this review may be useful for 
rationalize new herbal drug for vitiligo treatment.
Keywords: Vitiligo, Melanocyte, Ammi visnaga, Psoralea corylifolia, Regulatory T cells (Tregs) modulators.
INTRODUCTION
Vitiligo is a pigmentation disorder, in which pigmentation cells 
(melanocytes) of skin are destroyed, which results in smooth, white 
patches in the midst of normally pigmented skin. People with vitiligo 
may also associate with eye abnormalities and have a high incidence of 
diabetes mellitus, pernicious anemia, and thyroid disease [1].
History
The term vitiligo has been derived from the latin word “vitilus” 
meaning calf. The term was first coined by Celsus, Roman physician in 
the 1st Century A.D. [1]. According to him white patches of the disease 
resembled the white patches of a spotted calf. Vitiligo is an ancient 
disease mentioned in religious texts such as Holy Quran, Veda, and 
Bible. The disease is even documented as “Bai Dian Feng” in traditional 
Chinese medicine, “Shewetakusta” in Indian classic Atharva Veda, 
“Kilas” in Vinay Pitah (Buddist sacred book) and “Bars,” and “Phulbehri” 
in Arabic and Punjabi language [2].
Prevalence
It affects approximately 1–2% of world’s population, but the prevalence 
has been reported as high as 4% among some South Asian, Mexican, 
and American populations. In hospital Kuala Lumpur, Malaysia during 
the period of 2003–2007, approximately 2.2% new cases have been 
reported for this disease within the same period [3].
Epidemiology
It affects individuals of all age, races, ethnicity, and skin types. In 
Malaysia, vitiligo has been reported among all ethnic races [4]. Dark 
skin persons (African and Asian) usually face more stigmatization, 
discrimination and more possibly psychosocial problems [5].
Types of vitiligo
In general, it is classified according to the distribution, pattern, and 
extent of depigmentation. According to Nordlund and Lerner [6], it has 
been classified into three types as i) localized, ii) generalized, and iii) 
universal vitiligo. Localized vitiligo is again sub-classified as focal and 
segmental, whereas generalized vitiligo into acrofacial, vulgaris, and 
mixed subtypes [7].
Pigment biochemistry
Melanin is the major skin pigment, synthesized by specialized cells 
called melanocytes. Melanin is formed through series of oxidative 
reactions involving the amino acid tyrosine in the presence of 
tyrosinase (enzyme). Melanocytes synthesize the melanin within 
membrane-bound organelles called melanosomes, and later 
melanosomes are transferred through dendrites to surrounding 
keratinocytes. Each epidermal melanocyte secretes melanosomes 
to approximately 40 keratinocytes (1:40) in the neighborhood, and 
this entire unit is known as epidermal melanin unit. Thus, the type 
(eumelanin/pheomelanin) and amount of melanin synthesized by 
the melanocyte and its distribution in the surrounding keratinocytes 
determine the actual color of the healthy skin. Four major steps 
which are involved in melanogenesis process, they are (1) the 
vdeelopment of melanocyte precursor cells (melanoblasts) and 
their migration from the neural crest to peripheral sites; (2) 
differentiation of melanoblasts into melanocytes; (3) survival and 
proliferation of melanocytes; and (4) formation of melanosomes and 
production of melanin [8]. All the four steps are important for normal 
melanin biosynthesis, any disturbance in the melanin pathway 
results in either hypopigmentation (example albinism and vitiligo) 
or hyperpigmentation of skin (for example, Addison’s disease and 
melasma).
Etiology of Vitiligo
Although vitiligo is extensively studied in the past five decades, its 
etiology is still unclear. 13 prevailing theories of vitiligo (as shown in 
the Fig. 1) have been reviewed by Speeckaert et al. [9]; however, none 
of these hypotheses explain the entire spectrum of the vitiligo disease.
Diagnosis of vitiligo
Wood’s light has been used to diagnose the vitiligo in the patients 
having skin type I and II [10].
© 2018 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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TREATMENT OF VITILIGO
Many modalities have been used and continue to be used for the 
treatment (as shown in Fig. 2).
In spite of different treatment modalities, it is often troublesome 
and frustrating both for the patients as well as the physician [10]. To 
date, no Food and Drug Administration approved medical treatments 
for vitiligo was available [11]. In the present review, we highlight 
the role of herbal medicine in vitiligo treatment. In the treatment of 
vitiligo by oral use of Psoralea corylifolia/Ammi majus plant extracts 
particularly when combined with sun exposure, was known in ancient 
India, China, Egypt, and Japan [12]. El Mofty [13] was pioneer in Egypt 
for vitiligo treatment who used the crystallized active components of 
A. majus mainly 8-methoxypsoralen, both alone and in combination 
with exposure to sunlight. Later a number of natural psoralens were 
reported in certain plant families such as Umbelliferae (Parsley, 
Parsnip, and Celery), Rutaceae (Bergamot fruits, Gas plant, Cloves, and 
Citrus fruits), and Moraceae (Figs). 13 herbs (as shown in the Table 1) 
used in the treatment of vitiligo have phototoxic property, which have 
been used either alone or in combination with sunlight/ultraviolet 
light (UV).
In addition to these 21 terrestrial plants in Peninsular Malaysia have 
been reported for phototoxic activity [34]. Another 13 herbs used in the 
treatment of vitiligo have known to induce melanocyte proliferation, 
migration and, in turn, stimulant melanogenesis process (as shown 
in Table 1). In addition to these three herbs have been reported for 
melanogenic activity [35] two herbs, namely P. corylifolia L and Tribulus 
terrestris L reported to have both phototoxic and induce melanocyte 
proliferation/migration properties. Whereas three herbs such as 
Cnidium officinale, Eclipta alba L, and Eclipta prostrate L reported to 
have both phototoxic and immunomodulatory properties. Angelica 
sinensis, only herb reported to have phototoxic, induce melanocyte 
proliferation/migration, and immunomodulatory properties (as shown 
in Table 1).
Apart from individual herbs, certain herbal products have been 
reported for vitiligo treatment includes
1. Anti-vitiligoTM - An herbal formulation from True Herbals, Lahore, 
Pakistan and the main herbal ingredients are Berberis vulgaris L., 
Cocos nucifera L., Nigella sativa L, and P. corylifolia L [1].
2. Callumae - a product, which contains three herbs such as Ammi 
visnaga L., Ginkgo biloba, and P. kurroa Royle Ex Benth [18].
3. Herbo-mineral capsule (ALG-06), which contains four herbs, namely 
Azadirachta indica A Juss, P. corylifolia L., Punica granatum L, and 
Trigonella foenum-graecum L [36].
4. Kakodumbaradi thaila - An herbal formulation which contains four 
herbs such as Atylosia trinervia (DC.) Gamble, Eclipta prostrata L., 
Ficus hispida Linn, and Sesamum indicum L [37].
5. KalawallaR - An herbal formulation from American Lifestyle, 
New York, USA, and the main herbal ingredients are Polypodium 
leucotomos, which has been proven to have immune-modulatory 
activity [1].
6. TolenormTM - a product, which contains five herbs such as Cocos 
nucifera L., Indigofera tinctoria Linn, Piper longum Linn, P. corylifolia 
L, and Wrighti tinctoria R.Br [38]
7. VitiloR lotion, which contains eight herbs such as Acorus calamus L., 
A. indica A Juss, Curcuma amada Roxb, Curcuma longa L., Pongamia 
glabra L., P. corylifolia L., Pterocarpus santalinum L, and Rubia 
cordifolia L [39].
8. Vitilax - An herbal formulation, which contains 10 herbs, namely A. 
sinensis Oliv, Astragalus membranaceus Fisch, Atractylodes japonica 
Koidz, Cassia occidentalis L., Cnidium officinale, Curcuma longa L., 
Cuscuta japonica Choisy, Paeonia lactiflora Pall, Salvia miltiorrhiza, 
and Tribulus terrestris L [18].
Six trials investigated the use of herbs in the treatment of vitiligo 
has been discussed by Szczurko and Boon [14]. Four of these clinical 
trials utilized plants (such as P. kurroa, Ammi visnaga, and two P. 
leucotomos) all were given orally in conjunction with (UVA or UVB) 
phototherapy; one clinical trial the use of oral Ginkgo biloba (40 mg) 
alone and another one trial also use the extract of Cucumis melo alone, 
without any conjunction phototherapy. In a nutshell, no converging 
results have been drawn for these clinical trials [14]. Apart from 
these trials, one more pilot trial has been carried using Ginkgo biloba 
(60 mg) alone [40]. Chakraborthy et al. [41] reported that A. indica A 
Juss (leaf glycoprotein) inhibits regulatory T cells in cancer, which may 
also utilize for vitiligo treatment (as this one of an herbal ingredient 
of Herbo-mineral capsule [ALG-06]). Recently, Zhu et al. [42] reported 
epigallocatechin-3-gallate (EGCG) from green tea has a new therapeutic 
agent for vitiligo.
MISCELLANEOUS
Table 2 provides a comprehensive summary of the patents pertaining to 
vitiligo treatment using both natural and synthetic products.
Pandey [60] reported a novel ayurvedic formulation (containing of 
seven herbs such as Aegle marmelos, A. indica, E. alba, Ficus religiosa, 
Ocimum tenuiflorum, Phylanthus emblica, and P. corylifolia) for the 
treatment of vitiligo. Recently, Abrus precatorius (seeds), A. majus 
(seeds), and Pterocarpus marsupium (heartwood) have been used for 
the treatment of vitiligo [61-63] Mosensons et al. [64] reported that 
mutant heat shock protein (HSPiQ435A) as a potent agent for treating 
vitiligo.
FUTURE PERSPECTIVES
In recent years efforts to discover and develop new vitiligo drugs 
have gained much attention among the researchers, as result of 
Fig. 1: Represents various theories of Vitiligo
Fig. 2: Represents different treatment modalities of vitiligo
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the recognition of the worldwide importance of fighting vitiligo 
disease. Moreover, world vitiligo day has been observed on June 25 
every year as a way to create global awareness. There is a high need 
to have public-private collaboration and long-term action plan to 
discover, develop, and deliver new drugs for vitiligo treatment. 
Recent understanding the multifactorial, multistep etiology of 
vitiligo, has identified many potential targets for new drugs. New 
promising targets may include Interleukin-17 (IL-17) inhibition, 
tumor necrosis factor-alpha inhibition, heat shock protein-70i 
(HSP70i) inhibition, keratinocyte turnover modulators, and 
regulatory T cells (Tregs) modulators. Time is our tough judge, 
and really no one wants to loss the golden opportunity to develop 
new, safe, affordable, and effective vitiligo drugs from a natural 
source.
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Table 1: Herbs used for Vitiligo treatment
S. no A) Herbs having photosensitizing/phototoxic property Reference
1. A. visnaga Szczurko and Boon [14]
2. A. lancea Wat et al. [15]
3. A. japonica Bark et al. [16]
4. C. tinctorius Wat et al. [15]
5. F. carica Bark et al. [16]
6. F. hispida Srivastava [17]
7. Hypericum sp. Yoon et al. [18]
8. P. kurroa Szczurko and Boon [14]
9. P. tenuifolia Yoon et al [18]
10. P. leucotomos Szczurko and Boon [14]
11. R. crispus Yoon et al. [18]
12. S. anacardium Srivastava [17]
13. X. strumarium Bark et al.. [16]
B) Herbs having melanocyte proliferation/migration stimulation property Reference
14. A. dahuricae Zhang et al.. [19]
15. A. membranaceus Yoon et al.. [18]
16. C. occidentalis Babitha et al.. [20]
17. C. chinensis Li et al.. [21]
18. F. carthami Zhang et al.. [19]
19. L. bicolor Yoon et al.. [18]
20. L. lucidum Yoonet al.. [18]
21. M. scurfpea Mou et al.. [22]
22. P. nigrum Lin et al.[23]
23. P. corylifolia Liet al. [21]
24. R. schlippenbachii Yoon et al.. [18]
25. S. miltiorrhiza Chiang et al.. [24]
26. T. terrestris Li et al.. [21]
C) Herbs having immunomodulatory property Reference
26. C. pilosula Zhuang et al.. [25]
27. C. melo Dhasarathan et al.. [26]
28. G. biloba Parsad et al. [27]
29. N. sativa Paarakh [28]
30. P. vulgaris Yoon et al.. [18]
D) Herbs having both phototoxic and melanocyte proliferation/migration stimulation 
properties
Reference
31. P. corylifolia Khushboo et al..[29] and Li et al. [21]
32. T. terrestris Yoon et al..[18] and Li et al.. [21]
E) Herbs having both phototoxic and immunomodulatory properties Reference
33. C. officinale Bark et al..[16] and Joseph de la Cruz 
et al.. [30]
34. E. alba Wat et al..[15] and Jayathirtha and 
Mishra [31]
35. E. prostrata Wat et al..[15] and Karthikumar et al.. [32]
F) Herbs having phototoxic, melanocyte proliferation/migration stimulation and 
immunomodulatory properties
Reference
36. A. sinensis Yoon et al. [18]; Deng & Yang[33] and Zhuang 
et al.[25] 
A visnaga: Ammi visnaga, A. lancea: Atractylodes lancea, A. japonica: Atractylodes japonica, C. tinctorius: Carthamus tinctorius, F. carica: Ficus carica, F. hispida: Ficus 
hispida, P. kurroa: Picrorhiza kurroa, P. tenuifolia: Polygala tenuifolia, P. leucotomos: Polypodium leucotomos, R. crispus: Rumex crispus, S. anacardium: Semecarpus 
anacardium, X. strumarium: Xanthium strumarium, A. dahuricae: Angelicae dahuricae, A. membranaceus: Astragalus membranaceus, C. occidentalis: Cassia occidentalis, 
C. chinensis: Cuscuta chinensis, F. carthami: Flos carthami, L. bicolor: Lespedeza bicolor, L. lucidum: Ligustrum lucidum, M. scurfpea: Malytea scurfpea, P. nigrum: 
Piper nigrum, P. corylifolia: Psoralea corylifolia, R. schlippenbachii: Rhododendron schlippenbachii, S. miltiorrhiza: Salvia miltiorrhiza, T. terrestris: Tribulus terrestris, 
C. pilosula: Codonopsis pilosula, C. melo: Cucumis melo, G. biloba: Ginkgo biloba, N. sativa: Nigella sativa, P. vulgaris: Prunella vulgaris, P. corylifolia: Psoralea corylifolia, 
T. terrestris: Tribulus terrestris, C. officinale: Cnidium officinale, E. alba: Eclipta alba, E. prostrate: Eclipta prostrate, A. sinensis: Angelica sinensis
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